María Fernández Abad

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

University of Southern California(Current)

Eli Lilly (Spain)

University of California, Los Angeles

Hospital General Universitario Gregorio Marañón

Orlando Health

María Fernández Abad is an author at University of Southern California specializing in metastatic breast cancer treatment, breast cancer hormone therapy, and cancer pharmacology.

Publications per year

2016–2017

Publications

breast cancer, early stage Interim results from neoMONARCH: A neoadjuvant phase II study of abemaciclib in postmenopausal women with HR + /HER2- breast cancer (BC)

Sara A. Hurvitz, María Fernández Abad, Regan Rostorfer et al. · Annals of Oncology · 2016 · 19 citations

Medicine, Oncology, Pharmacology +17

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer

Sara A. Hurvitz, Miguel Martín, María Fernández Abad et al. · Cancer Research · 2017 · 15 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2